echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Disruption of N-glycan expression on tumor cells improves the efficacy of chimeric antigen receptor T cells against solid malignancies

    Disruption of N-glycan expression on tumor cells improves the efficacy of chimeric antigen receptor T cells against solid malignancies

    • Last Update: 2022-02-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Deglycosylation

    Chimeric antigen receptor (CAR) T cells are less effective for solid tumors than for hematological malignancies


    One of the resistance mechanisms that tumor cells use to prevent CAR-T cell killing is through glycosylation of surface proteins


    However, for the first time in a human solid tumor study, some unique barriers have been identified that lead to poor efficacy


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.